Connection

Andrew Kraft to Phosphorylation

This is a "connection" page, showing publications Andrew Kraft has written about Phosphorylation.
Connection Strength

1.540
  1. Insulin receptor substrate 1 is a substrate of the Pim protein kinases. Oncotarget. 2016 Apr 12; 7(15):20152-65.
    View in: PubMed
    Score: 0.104
  2. Regulation of prostate stromal fibroblasts by the PIM1 protein kinase. Cell Signal. 2015 Jan; 27(1):135-46.
    View in: PubMed
    Score: 0.094
  3. The Pim-1 protein kinase is an important regulator of MET receptor tyrosine kinase levels and signaling. Mol Cell Biol. 2014 Jul; 34(13):2517-32.
    View in: PubMed
    Score: 0.091
  4. Regulation of Skp2 levels by the Pim-1 protein kinase. J Biol Chem. 2010 Sep 17; 285(38):29128-37.
    View in: PubMed
    Score: 0.070
  5. A small molecule inhibitor of Pim protein kinases blocks the growth of precursor T-cell lymphoblastic leukemia/lymphoma. Blood. 2010 Jan 28; 115(4):824-33.
    View in: PubMed
    Score: 0.067
  6. Novel benzylidene-thiazolidine-2,4-diones inhibit Pim protein kinase activity and induce cell cycle arrest in leukemia and prostate cancer cells. Mol Cancer Ther. 2009 Jun; 8(6):1473-83.
    View in: PubMed
    Score: 0.065
  7. PIM1 protein kinase regulates PRAS40 phosphorylation and mTOR activity in FDCP1 cells. Cancer Biol Ther. 2009 May; 8(9):846-53.
    View in: PubMed
    Score: 0.065
  8. Cell cycle dependent antagonistic interactions between paclitaxel and carboplatin in combination therapy. Cancer Biol Ther. 2007 Jul; 6(7):1067-73.
    View in: PubMed
    Score: 0.057
  9. Regulation of RUNX1/AML1 during the G2/M transition. Leuk Res. 2007 Jun; 31(6):839-51.
    View in: PubMed
    Score: 0.054
  10. Pim family kinases enhance tumor growth of prostate cancer cells. Mol Cancer Res. 2005 Aug; 3(8):443-51.
    View in: PubMed
    Score: 0.050
  11. Phosphorylation of AML1/RUNX1 regulates its degradation and nuclear matrix association. Mol Cancer Res. 2005 Jul; 3(7):391-401.
    View in: PubMed
    Score: 0.049
  12. RAS, MYC, and sensitivity to tumor necrosis factor-alpha-related apoptosis-inducing ligand-induced apoptosis. Cancer Res. 2005 Feb 15; 65(4):1615-6; author reply 1616-7.
    View in: PubMed
    Score: 0.048
  13. Phorbol ester treatment of K562 cells regulates the transcriptional activity of AML1c through phosphorylation. J Biol Chem. 2004 Dec 17; 279(51):53116-25.
    View in: PubMed
    Score: 0.047
  14. Pim-1 protein kinase is nuclear in Burkitt's lymphoma: nuclear localization is necessary for its biologic effects. Anticancer Res. 2003 Jan-Feb; 23(1A):167-78.
    View in: PubMed
    Score: 0.041
  15. Distinct domains of the human granulocyte-macrophage colony-stimulating factor receptor alpha subunit mediate activation of Jak/Stat signaling and differentiation. Blood. 2001 Mar 15; 97(6):1662-70.
    View in: PubMed
    Score: 0.037
  16. EDC3 phosphorylation regulates growth and invasion through controlling P-body formation and dynamics. EMBO Rep. 2021 04 07; 22(4):e50835.
    View in: PubMed
    Score: 0.036
  17. Regulation of dual-specificity phosphatases M3/6 and hVH5 by phorbol esters. Analysis of a delta-like domain. J Biol Chem. 2000 Oct 13; 275(41):31755-62.
    View in: PubMed
    Score: 0.036
  18. The role of the Smad3 protein in phorbol ester-induced promoter expression. J Biol Chem. 1999 Dec 24; 274(52):36987-94.
    View in: PubMed
    Score: 0.034
  19. Phosphorylation of DEPDC5, a component of the GATOR1 complex, releases inhibition of mTORC1 and promotes tumor growth. Proc Natl Acad Sci U S A. 2019 10 08; 116(41):20505-20510.
    View in: PubMed
    Score: 0.033
  20. Activation of the mitogen-activated protein kinase pathway in U937 leukemic cells induces phosphorylation of the amino terminus of the TATA-binding protein. Cell Growth Differ. 1998 Aug; 9(8):667-76.
    View in: PubMed
    Score: 0.031
  21. Cytoplasmic domains of the human granulocyte-macrophage colony-stimulating factor (GM-CSF) receptor beta chain (hbetac) responsible for human GM-CSF-induced myeloid cell differentiation. J Biol Chem. 1998 Jul 31; 273(31):19411-8.
    View in: PubMed
    Score: 0.031
  22. The kinase domain of Jak2 mediates induction of bcl-2 and delays cell death in hematopoietic cells. J Biol Chem. 1997 May 09; 272(19):12350-8.
    View in: PubMed
    Score: 0.028
  23. Inhibitors of cyclin-dependent kinase and cancer. J Mol Med (Berl). 1995 Oct; 73(10):509-14.
    View in: PubMed
    Score: 0.025
  24. Inhibition of leukemic cell growth by the protein kinase C activator bryostatin 1 correlates with the dephosphorylation of cyclin-dependent kinase 2. Cancer Res. 1995 Sep 01; 55(17):3716-20.
    View in: PubMed
    Score: 0.025
  25. Signal transduction by a CD16/CD7/Jak2 fusion protein. J Biol Chem. 1995 Aug 04; 270(31):18420-7.
    View in: PubMed
    Score: 0.025
  26. The amino-terminal portion of the JAK2 protein kinase is necessary for binding and phosphorylation of the granulocyte-macrophage colony-stimulating factor receptor beta c chain. J Biol Chem. 1995 Jun 09; 270(23):13814-8.
    View in: PubMed
    Score: 0.025
  27. In vitro association between the Jun protein family and the general transcription factors, TBP and TFIIB. Biochem J. 1995 Feb 01; 305 ( Pt 3):967-74.
    View in: PubMed
    Score: 0.024
  28. Phosphorylation of transcription factors. Methods Enzymol. 1995; 254:550-64.
    View in: PubMed
    Score: 0.024
  29. Multiple signal transduction pathways mediate c-Jun protein phosphorylation. Cell Growth Differ. 1993 May; 4(5):377-85.
    View in: PubMed
    Score: 0.021
  30. Regulation of jun/AP-1 oncoproteins by protein phosphorylation. Adv Second Messenger Phosphoprotein Res. 1993; 28:261-9.
    View in: PubMed
    Score: 0.021
  31. Affinity-purified c-Jun amino-terminal protein kinase requires serine/threonine phosphorylation for activity. J Biol Chem. 1992 Aug 25; 267(24):17001-5.
    View in: PubMed
    Score: 0.020
  32. Phorbol ester-induced amino-terminal phosphorylation of human JUN but not JUNB regulates transcriptional activation. Proc Natl Acad Sci U S A. 1992 Aug 01; 89(15):7247-51.
    View in: PubMed
    Score: 0.020
  33. Induction of differentiation and c-jun expression in human leukemic cells by okadaic acid, an inhibitor of protein phosphatases. J Cell Physiol. 1992 May; 151(2):415-26.
    View in: PubMed
    Score: 0.020
  34. Multiple phosphorylation sites are important for RUNX1 activity in early hematopoiesis and T-cell differentiation. Eur J Immunol. 2012 Apr; 42(4):1044-50.
    View in: PubMed
    Score: 0.020
  35. Lack of phosphorylation of lipocortin I in A431 epidermoid carcinoma cells treated with phorbol esters. Biochem Biophys Res Commun. 1989 Apr 28; 160(2):474-9.
    View in: PubMed
    Score: 0.016
  36. Synthesis and evaluation of novel inhibitors of Pim-1 and Pim-2 protein kinases. J Med Chem. 2009 Jan 08; 52(1):74-86.
    View in: PubMed
    Score: 0.016
  37. Bryostatin induces changes in protein kinase C location and activity without altering c-myc gene expression in human promyelocytic leukemia cells (HL-60). Oncogene. 1987 May; 1(2):111-8.
    View in: PubMed
    Score: 0.014
  38. AML1/RUNX1 phosphorylation by cyclin-dependent kinases regulates the degradation of AML1/RUNX1 by the anaphase-promoting complex. Mol Cell Biol. 2006 Oct; 26(20):7420-9.
    View in: PubMed
    Score: 0.013
  39. The PIM-2 kinase phosphorylates BAD on serine 112 and reverses BAD-induced cell death. J Biol Chem. 2003 Nov 14; 278(46):45358-67.
    View in: PubMed
    Score: 0.011
  40. Regulation of the c-jun gene in p210 BCR-ABL transformed cells corresponds with activity of JNK, the c-jun N-terminal kinase. Blood. 1998 Oct 01; 92(7):2450-60.
    View in: PubMed
    Score: 0.008
  41. Growth hormone receptor cytoplasmic domain differentially promotes tyrosine phosphorylation of signal transducers and activators of transcription 5b and 3 by activated JAK2 kinase. Mol Endocrinol. 1996 Nov; 10(11):1425-43.
    View in: PubMed
    Score: 0.007
  42. Stress-activated protein kinases bind directly to the delta domain of c-Jun in resting cells: implications for repression of c-Jun function. Oncogene. 1995 Mar 02; 10(5):849-55.
    View in: PubMed
    Score: 0.006
  43. Interaction of the growth hormone receptor cytoplasmic domain with the JAK2 tyrosine kinase. Endocrinology. 1994 Nov; 135(5):2228-39.
    View in: PubMed
    Score: 0.006
  44. Co-purification of mitogen-activated protein kinases with phorbol ester-induced c-Jun kinase activity in U937 leukaemic cells. Oncogene. 1993 Feb; 8(2):407-15.
    View in: PubMed
    Score: 0.005
  45. Interleukin-3 and bryostatin 1 mediate rapid nuclear envelope protein phosphorylation in growth factor-dependent FDC-P1 hematopoietic cells. A possible role for nuclear protein kinase C. J Biol Chem. 1989 Dec 25; 264(36):21896-901.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.